Therapeutic treatment of group A streptococcal infections
US6017528A · kind A · utility
43Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 1999 |
| Grant date | Jan 25, 2000 |
| Priority date | — |
| Expiry date | Feb 25, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions containing Group C streptococcal phage associated lysin enzyme for the prophylactic and therapeutic treatment of Streptococcal infections, including the infection commonly known as strep throat. Methods for therapeutically and prophylactically treating such infections also are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.